(Q34472677)

2 August 2017

1 reference

title

Renal transport of antibiotics and nephrotoxicity: a review (English)

1 reference

2 August 2017

0 references

Fanos V

1

1 reference

PubMed ID

11760211

2 August 2017

Cataldi L

series ordinal

2

1 reference

PubMed ID

11760211

2 August 2017

language of work or name

1 reference

1 October 2001

1 reference

2 August 2017

Journal of Chemotherapy

1 reference

2 August 2017

13

1 reference

2 August 2017

5

1 reference

2 August 2017

461-472

1 reference

Drug secretion systems in renal tubular cells: functional models and molecular identity

2 August 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Renal epithelial polarity in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Drug-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Antibacterial-induced nephrotoxicity in the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

The role of transport in chemical nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Renal ischemia: a new perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Drug excretion mediated by a new prototype of polyspecific transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Cloning and characterization of two human polyspecific organic cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Expression cloning of a rat liver Na(+)-independent organic anion transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

RENAL EXTRACTION OF PARA-AMINOHIPPURATE IN INFANTS AND CHILDREN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Genetic analysis of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Prevention of drug-induced nephrotoxicity in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Nephrotoxicity of aminoglycoside antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Metabolic interactions between drugs and renal tubulo-interstitial cells: Role in nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Urinary enzymes, nephrotoxicity and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Prostaglandin receptors: their role in regulating renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

NSAID-induced nephrotoxicity from the fetus to the child

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Metabolism and effects of epidermal growth factor and related growth factors in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Controlled Comparison of Gentamicin and Tobramycin Nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Once versus thrice daily gentamicin in patients with serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

What is the evidence for once-daily aminoglycoside therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Kinetic model for gentamicin dosing with the use of individual patient parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Candida infections in newborns: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Amphotericin B: current understanding of mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Amphotericin B toxicity. A follow-up report of 53 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Amphotericin B therapy in children; a review of the literature and a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Risk factors for Amphotericin B-associated nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Drug-induced nephrotoxicity. Aetiology, clinical features and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Amphotericin B-induced nephrotoxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Lipid formulations of amphotericin B: clinical efficacy and toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Lipid-based amphotericin B for the treatment of fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Renal sparing by amphotericin B colloidal dispersion: clinical experience in 572 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Glycopeptides and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Vancomycin ototoxicity and nephrotoxicity. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Chrononephrotoxicity in rat of a vancomycin and gentamicin combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

A review of teicoplanin in the treatment of serious neonatal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

The comparative efficacy and safety of teicoplanin and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Mechanisms of cephalosporin nephrotoxicity: a comparison of cephaloridine and cephaloglycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

Antibiotic prophylaxis in children with relapsing urinary tract infections: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.461

10.1179/JOC.2001.13.5.461

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11760211